For citations:
Krasnov VS, Abramova MP, Bakalova MA, Bezvodinskikh AI, Bembeeva RT, Gasanova ZS, Evdoshenko EP, Zhukovskaya NV, Zaplakhova OV, Ivanova SP, Ignateva OS, Kasatkin DS, Korobko DS, Krivomlina EV, Kushtynova VE, Lebedev VM, Nilov AI, Novikova ES, Rybina EV, Sokolova AА, Streknev AG, Sutormin MV, Tokareva ER, Khachanova NV, Cherepianskii MS, Shumilina MV, Yurchenko YN, Davydovskaia MV. Experience of satralizumab administration in patients with neuromyelitis optica spectrum disorder in the Russian Federation. Meditsinskiy sovet = Medical Council. 2026;(3):114-129. (In Russ.) https://doi.org/10.21518/ms2026-042
JATS XML
































